You can buy or sell Lantheus and other stocks, options, ETFs, and crypto commission-free!
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. Read More The firm's operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
North Billerica, Massachusetts
52 Week High
52 Week Low
Yahoo FinanceMay 8
Here’s What Hedge Funds Think About Lantheus Holdings Inc (LNTH)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent?
Yahoo FinanceMay 8
Does Market Volatility Impact Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Share Price?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Lantheus Holdings, Inc. (NASDAQ:LNTH) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. First, we have company specific volatility, which is the price gyrati...
Yahoo FinanceMay 7
Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference
NORTH BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Holdings, Inc. (the “Company”) (LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that Mary Anne Heino, President and Chief Executive Officer, and Robert Marshall, Chief Financial Officer, will present at the 2019 UBS Global Healthcare Conference at 1:00 p.m. ET on Tuesday, May 21 at the Grand Hyatt ...
Expected Jul 31, After Hours